Some well-established fusion genes have also been shown to be promiscuous, examples including MLL- in leukemias, EWS- in sarcomas, RET- in carcinomas and TMPRRS2- and ETV1-fusions in prostate cancer [4], [7], [30], [31]. This evidence concerns the gene KMT2A and prostate carcinoma.